Not applicableStudy completedNCT01340989What this trial is testingCO2 Absorption During LaparoscopyWho this might be right forPneumoperitoneum University Hospital, Gasthuisberg 60
Testing effectiveness (Phase 2)Ended earlyNCT02900560What this trial is testingStudy of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian CancerWho this might be right forEpithelial Ovarian Cancer Translational Research in Oncology 34
Not applicableUnknownNCT06512896What this trial is testingClinical Study on Intraluminal Injection of FOLactisWho this might be right forSolid TumorImmune ResponsePleural Effusion, Malignant+1 more The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Very early researchStudy completedNCT01747798What this trial is testingAuranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forRecurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer Mayo Clinic 10
Testing effectiveness (Phase 2)Study completedNCT03161132What this trial is testingResistant Ovarian Cancer, Olaparib and Liposomal DoxorubicinWho this might be right forAdvanced Ovarian Cancer Grupo Español de Investigación en Cáncer de Ovario 32
Testing effectiveness (Phase 2)Study completedNCT00939809What this trial is testingA6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CarcinomaMalignant Ovarian Mixed Epithelial TumorOvarian Brenner Tumor+7 more Gynecologic Oncology Group 31
Not applicableStudy completedNCT00997633What this trial is testingSingle-photon Emission Computed Tomography (SPECT) to Predict Peritoneal ChemotherapyWho this might be right forPeritoneal Carcinomatosis Uppsala University 51
Not applicableActive Not RecruitingNCT02113384What this trial is testingLocally Advanced Rectal Cancer - Exfoliated Peritoneal Tumor CellsWho this might be right forRectal Cancer Oslo University Hospital 231
Testing effectiveness (Phase 2)Study completedNCT00132067What this trial is testingVorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity CancerWho this might be right forPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer National Cancer Institute (NCI) 60
Very early researchActive Not RecruitingNCT05415709What this trial is testingHyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous Adenocarcinoma+30 more Ohio State University Comprehensive Cancer Center 35
Early research (Phase 1)UnknownNCT04029909What this trial is testingA Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerWho this might be right forOvarian Epithelial CancerFallopian Tube CancerPrimary Peritoneal Cancer Lee's Pharmaceutical Limited 12
Not applicableStudy completedNCT01538498What this trial is testingDevelopment for the Peritoneal Carcinomatosis Index (PCI) in Ovarian CancerWho this might be right forOvarian Cancer National Cancer Center, Korea 134
Early research (Phase 1)Study completedNCT00458809What this trial is testingIntraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal CancerWho this might be right forCarcinoma of the AppendixColorectal CancerPrimary Peritoneal Cavity Cancer Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Study completedNCT01248962What this trial is testingStandard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal CancerWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer Memorial Sloan Kettering Cancer Center 146
Testing effectiveness (Phase 2)Study completedNCT03026062What this trial is testingDurvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT00030446What this trial is testingErlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer NCIC Clinical Trials Group 50
Large-scale testing (Phase 3)Study completedNCT00052962What this trial is testingDebulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal CarcinomatosisWho this might be right forGastrointestinal Neoplasm National Cancer Institute (NCI) 30
Very early researchStudy completedNCT02111941What this trial is testingVaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more Mayo Clinic 19
Testing effectiveness (Phase 2)Ended earlyNCT00522301What this trial is testingSorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second RemissionWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT07514494What this trial is testingIntensification Treatment of Ovarian Cancer by PIPACWho this might be right forAdvanced Epithelial Ovarian CancerPeritoneal Carcinomatosis Moscow Regional Oncological Dispensary 160